MEZOO will expand the measurement functions of its multi-parameter wearable patient monitor, HiCardi M350, starting next year.
The M350 received approval for SpO₂ (oxygen saturation) measurement in September, and MEZOO aims to obtain approval for blood pressure measurement within this year. The company plans to pursue national health insurance reimbursement for these functions in the first quarter of next year. Because the M350 already has the hardware needed for SpO₂ and blood pressure measurement, the new functions can be added through a software.
According to the report, MEZOO's patient monitor revenue in the first half of this year reached about KRW 4.67 billion, already exceeding its total for last year.
The next-generation model, M150, has completed its hardware configuration and entered performance testing. It has built-in Wi-Fi, so it can transmit vital signs without a separate gateway.
Source : Etoday (Korean) https://www.etoday.co.kr/news/view/2642365

